CompoAtlas

Bone Builder

Bone Builder, licence 80060875: active licence in Health Canada data. The French and European references below do not constitute authorisation for sale in France or an assessment of safety or efficacy.

Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

Natural health product licensed in Canada

Other names
L'ORGANIQUE Bone Builder, Super Natural Bone Builder
Licence holder
Wesbridge Biomedical Inc.
NPN or DIN-HM
80060875
Status
Active licence
Licence date
13 May 2015
Revision date
12 February 2019
Form
Capsule
Route of administration
Orale
Application type
Non traditionnelle

If this product were sold in France

A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.

Composition

Medicinal ingredient and sourcePer dosage unit, according to the sourceMaximum per day, adult
2-(3,7,11,15,19,23,27-Heptaméthyl-2,6,10,14,18,22,26-octacosaheptaényl)-3-méthyl-1,4-naphthalènedione totalement (E)

Source : Ménaquinone 7

5.0 microgrammesNot calculated
Calcium

Source : Carbonate de calcium

270.0 milligramme810,000 µg
Vitamine D3

Source : Cholécalciférol

Potency : 333.0 Unités internationales

8.33 microgrammesNot calculated
Magnésium

Source : Oxyde de magnésium

50.0 milligramme150,000 µg
Olea europea

Source : Olea europaea - feuille

Extract : Matériel brut sec

Extraction ratio : 5:1

Dry plant equivalent : 825 milligramme

Potency : 33.0 milligramme Oleuropein

165.0 milligrammeNot calculated

Non-medicinal ingredients

Cellulose microcristalline, Gélatine, Stéarate de magnésium

PopulationAgeQuantity per servingFrequency
AdultesNot specified1.0 Capsule3.0 Tous les jours

Uses authorised in Canada

Text supplied in English because no French text is available.

Helps in the development and maintenance of bones and teeth. Calcium intake, when combined with sufficient Vitamin D, a healthy diet and regular exercise may reduce the risk of developing osteoporosis. Helps in the absorption and use of calcium and phosphorus. Helps in tissue formation. Helps to maintain proper muscle function. Helps stimulate bone formation. Helps in the maintenance of bones.

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.

Warnings in Canada

No French warning text available in the imported data.

Warnings are available in English on the official record.

Source

Official Health Canada record, licence 80060875

The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.

List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).

List recorded in 2019. Photograph the packaging to check whether it has changed.

Has the product changed? Photograph the packaging.

List recorded in 2019. Photograph the packaging to check whether it has changed.

Enter to analyse, Shift+Enter for a new line